121 related articles for article (PubMed ID: 17502329)
1. Effect of drug combinations on admission for recurrent myocardial infarction.
van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
Heart; 2007 Oct; 93(10):1226-30. PubMed ID: 17502329
[TBL] [Abstract][Full Text] [Related]
2. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
[TBL] [Abstract][Full Text] [Related]
3. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
Björck L; Wallentin L; Stenestrand U; Lappas G; Rosengren A
Arch Intern Med; 2010 Aug; 170(15):1375-81. PubMed ID: 20696964
[TBL] [Abstract][Full Text] [Related]
4. Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies.
Kesselheim AS; Bykov K; Avorn J; Tong A; Doherty M; Choudhry NK
Ann Intern Med; 2014 Jul; 161(2):96-103. PubMed ID: 25023248
[TBL] [Abstract][Full Text] [Related]
5. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
7. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
Setoguchi S; Glynn RJ; Avorn J; Levin R; Winkelmayer WC
Am J Cardiol; 2007 Oct; 100(7):1061-7. PubMed ID: 17884362
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.
Bourgault C; Elstein E; Baltzan MA; Le Lorier J; Suissa S
Pharmacoepidemiol Drug Saf; 2001; 10(4):287-94. PubMed ID: 11760488
[TBL] [Abstract][Full Text] [Related]
9. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
[TBL] [Abstract][Full Text] [Related]
10. Repeat prescriptions of guideline-based secondary prevention medication in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care.
Kasteleyn MJ; Wezendonk A; Vos RC; Numans ME; Jansen H; Rutten GE
Fam Pract; 2014 Dec; 31(6):688-93. PubMed ID: 25106412
[TBL] [Abstract][Full Text] [Related]
11. The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction.
Di Martino M; Kirchmayer U; Agabiti N; Bauleo L; Fusco D; Perucci CA; Davoli M
BMJ Open; 2015 Jun; 5(6):e007866. PubMed ID: 26063569
[TBL] [Abstract][Full Text] [Related]
12. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis.
Hippisley-Cox J; Coupland C
BMJ; 2005 May; 330(7499):1059-63. PubMed ID: 15879390
[TBL] [Abstract][Full Text] [Related]
13. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
[TBL] [Abstract][Full Text] [Related]
14. Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study.
Lindhardsen J; Ahlehoff O; Gislason GH; Madsen OR; Olesen JB; Torp-Pedersen C; Hansen PR
Ann Rheum Dis; 2012 Sep; 71(9):1496-501. PubMed ID: 22402144
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.
Pipilis A; Andrikopoulos G; Lekakis J; Kalantzi K; Kitsiou A; Toli K; Floros D; Gaita D; Karalis I; Dragomanovits S; Kalogeropoulos P; Synetos A; Koutsogiannis N; Stougiannos P; Antonakoudis C; Goudevenos J;
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):85-90. PubMed ID: 19188809
[TBL] [Abstract][Full Text] [Related]
16. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.
Cambou JP; Simon T; Mulak G; Bataille V; Danchin N
Arch Mal Coeur Vaiss; 2007; 100(6-7):524-34. PubMed ID: 17893635
[TBL] [Abstract][Full Text] [Related]
17. Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction.
Shen L; Shah BR; Nam A; Holmes D; Alexander KP; Bhatt DL; Ho PM; Peterson ED; He B; Roe MT
Am Heart J; 2014 Jun; 167(6):840-5. PubMed ID: 24890533
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.
Tuppin P; Neumann A; Danchin N; de Peretti C; Weill A; Ricordeau P; Allemand H
Arch Cardiovasc Dis; 2010; 103(6-7):363-75. PubMed ID: 20800800
[TBL] [Abstract][Full Text] [Related]
19. Hospital case volume and appropriate prescriptions at hospital discharge after acute myocardial infarction: a nationwide assessment.
Schiele F; Capuano F; Loirat P; Desplanques-Leperre A; Derumeaux G; Thebaut JF; Gardel C; Grenier C
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):50-7. PubMed ID: 23233747
[TBL] [Abstract][Full Text] [Related]
20. Relation between combining evidence-based medications on mortality following myocardial infarction in patients with and without renal impairment.
Tay EL; Chan M; Tan V; Sim LL; Tan HC; Lim YT; Ho KT; Chia BL; Wong PS; Yeo TC
Acta Cardiol; 2010 Apr; 65(2):211-6. PubMed ID: 20458829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
